NF-κB and mitochondria cross paths in cancer: mitochondrial metabolism and beyond

•NF-κB governs energy homeostasis and promotes metabolic adaptation of cancer cells.•Metabolic alteration and mitochondria have been recognised as key players in cancer.•The interplay between NF-κB and mitochondria sustains oncogenesis. NF-κB plays a pivotal role in oncogenesis. This transcription f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Seminars in cell & developmental biology 2020-02, Vol.98, p.118-128
Hauptverfasser: Capece, Daria, Verzella, Daniela, Di Francesco, Barbara, Alesse, Edoardo, Franzoso, Guido, Zazzeroni, Francesca
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•NF-κB governs energy homeostasis and promotes metabolic adaptation of cancer cells.•Metabolic alteration and mitochondria have been recognised as key players in cancer.•The interplay between NF-κB and mitochondria sustains oncogenesis. NF-κB plays a pivotal role in oncogenesis. This transcription factor is best known for promoting cancer cell survival and tumour-driving inflammation. However, several lines of evidence support a crucial role for NF-κB in governing energy homeostasis and mediating cancer metabolic reprogramming. Mitochondria are central players in many metabolic processes altered in cancer. Beyond their bioenergetic activity, several facets of mitochondria biology, including mitochondrial dynamics and oxidative stress, promote and sustain malignant transformation. Recent reports revealed an intimate connection between NF-κB pathway and the oncogenic mitochondrial functions. NF-κB can impact mitochondrial respiration and mitochondrial dynamics, and, reciprocally, mitochondria can sense stress signals and convert them into cell biological responses leading to NF-κB activation. In this review we discuss their emerging reciprocal regulation and the significance of this interplay for anticancer therapy.
ISSN:1084-9521
1096-3634
DOI:10.1016/j.semcdb.2019.05.021